Can a common diabetes pill protect the heart in patients with heart failure?

NCT ID NCT07288749

Not yet recruiting Disease control Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 05, 2026 · Updated 17 times

Summary

This study tests the drug glimepiride in about 1,484 adults with type 2 diabetes and chronic heart failure with reduced pumping ability. The goal is to see if the drug can lower the risk of heart-related death, need for a heart transplant, or worsening heart failure that requires hospital care. Participants will receive either glimepiride or a placebo, and researchers will track their heart health over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Tongji Hostipal

Wuhan, Hubei, 430030, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC HEART FAILURE (CHF) TYPE 2 DIABETES MELLITUS (T2DM)